Skip to main content

Pneumocystis Jirovecii Pneumonia Complicating Systemic Vasculitis

A retrospecitive analysis of 62 patients with systemic vasculitis complicated by Pneumocystis jirovecii pneumonia (PJP) showed those with microscopic polyangiitis (MPA) had a higher mortality risk, possibly due to a higher prevalence of interstitial lung disease (ILD) in MPA.

From a total of 62 vasculitis-PJP patients, 48 had anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV), with microscopic polyangiitis (MPA) being the most common subtype (28 patients). Mortality was predicted by:

  • MPA (HR 4.33, p = 0.001)
  • concomitant aspergillosis (HR 2.68, p = 0.019)
  • higher D-dimer at PJP diagnosis (HR 1.07, p = 0.004) 

MPA patients were older (median 69 vs. 58 years, p = 0.001); and had more ILD (ILD: 78.6% vs. 35.3%, p = 0.001 and and fibrotic ILD (57.1% vs. 11.8%, p < 0.001). 

The authors suggest greater attention to PJP prophylaxis in managing systemic vasculitis patients, especially those with ILD and/or MPA.

ADD THE FIRST COMMENT

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

Disclosures
The author has no conflicts of interest to disclose related to this subject